X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

NATURE REVIEWS CANCER

期刊標題檢索 NAT REV CANCER 最新評論: Review speed: 3.0 | Submission acceptance rate: 25.0 Experience shar... (2023-05-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[NATURE REVIEWS CANCER]您好,您是該頁面的第 59942 位訪客。

期刊簡介
期刊名稱NATURE REVIEWS CANCER NATURE REVIEWS CANCER
LetPub Score
9.8
50 ratings
Rate

Reputation
10.0

Influence
9.7

Speed
9.3

期刊簡稱NAT REV CANCER
ISSN1474-175X
E-ISSN1474-1768
h-index396
CiteScore
CiteScoreSJRSNIPCiteScore Rank
111.9026.83711.501
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q11 / 230
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q12 / 404

自引率 (2023-2024)0.70%自引率趨勢
掲載範囲
Nature Reviews Cancer aims to be the premier source of reviews and commentaries for the scientific communities we serve. We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items. We want to provide an unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, Reviews and Perspectives relevant to cancer researchers, with our broad scope ensuring that the articles we publish reach the widest possible audience. 
官方網站https://www.nature.com/nrc
在線稿件提交https://mts-nrc.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2001
每年文章數45每年文章數趨勢
黃金OA百分比0.76%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ13/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1474-175X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Mostly invited contributions
參考鏈接
相關期刊 【NATURE REVIEWS CANCER】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330855
    CANCER RESEARCH312133
    BMC CANCER245476
    Asian Pacific Journal of Cancer Prevention219121
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191629
    CLINICAL CANCER RESEARCH181664
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176344
    ONCOLOGY REPORTS175027
    CA-A CANCER JOURNAL FOR CLINICIANS163630
  •  

    NATURE REVIEWS CANCER NATURE REVIEWS CANCER
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [NATURE REVIEWS CANCER] 的評論撰寫評論
作者: 黑山泽恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-31 09:28:55 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: Slow, 6-12 weeks
(0) 讚! | 黑山泽恩

作者: Junzheng


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-20 10:35:16 評論於
Hello, may I ask what the status is after you submit your manuscript? Is it initially "Manuscript received"? What is the status after it is assigned to a specific editor?
(0) 讚! | Junzheng

作者: 太山嘉懿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-05 11:35:47 評論於
Around 25
(0) 讚! | 太山嘉懿

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:54:50 評論於
Authors need to objectively evaluate whether the quality of their research work matches the level of the selected journal. Top-tier journals have high requirements for the originality of submissions. The acceptance rate of top journals like Nature is below 10%, and most submissions are rejected at the desk review stage
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:46:12 評論於
Please translate the following passage into English and Japanese
(0) 讚! | 维尔娜菲茨杰拉德

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:21:03 評論於
Can I submit directly to top journals like Nature/Science? Will they provide feedback?
(0) 讚! | 破戒阳平

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:45:59 評論於
How many alternative journals are generally selected for each journal gradient?
(0) 讚! | Oswald Edie

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-15 11:33:24 評論於
Who can predict how many points there will be next year?
(0) 讚! | 凌霄高洁

作者: Anonymous


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-17 17:14:48 評論於
This year's impact factor is conservatively estimated between 35-40.
(0) 讚! | Anonymous

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-08-19 13:03:00 評論於
Journal Homepage URL: http://www.Nature.com/nrc/index.html
(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [NATURE REVIEWS CANCER] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*